Paramunity inducers based on attenuated rabbit myxoma virus

Details Paramunity inducers based on attenuated rabbit myxoma virus Paramunity inducers based on attenuated rabbit myxoma virus

2005-01-21

2009-02-24

Campell, Bruce (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Inactivation or attenuation; producing viral subunits

C435S005000, C435S070100, C435S235100, C435S237000, C435S238000, C424S232100

Reexamination Certificate

active

07494799

ABSTRACT:
The invention relates to monoparamunity inducers that are based on paramunizing viruses or viral components of a myxoma virus strain of diseased rabbits that show general symptoms of the disease. The invention also relates to a method for producing the inducers and to their use as drugs for the regulatory optimization of the paramunizing activities for use in the prophylaxis and therapy of various human and animal dysfunctions.

REFERENCES:
patent: 6340462 (2002-01-01), Paoletti
patent: 6805870 (2004-10-01), Mayr
patent: 2003/0013190 (2003-01-01), Mayr
patent: 2006/0147419 (2006-07-01), Perera et al.
patent: 0 669 133 (1995-08-01), None
Ogino et al., Cell Fusion Activities of Hantaan Virus Envelope Glycoproteins, 2004, Journal of Virology, vol. 78, No. 19. pp. 10776-10782.
Mossman, K. et al., “Myxoma Virus M-T7 a Secreted Homolog of the Interferon-γ Receptor, Is a Critical Virulence I-Actor for the Development of Myxomatosis in European Rabbits,” Virology, vol. 215, Article No. 0003, pp. 17-30, (1996).
Upton, C. et al., “Myxoma Virus Expresses a Secreted Protein with Homology to the Tumor Necrosis Factor Receptor Gene Family that Contributes to Viral Virulence,” Virology, vol. 184, pp. 370-382, (1991).
Saito, J. K. et al., “Attenuation of the Myxoma Virus and Use of The Living Attenuated Virus as an Immunizing Agent for Myxomatosis,” The Journal of Infectious Diseases, vol. 114, pp. 417-428, (Dec. 1964).
McCabe, V. J. et al., “Vaccination of Cats with an Attenuated Recombinant Myxoma Virus Expressing Feline Calicivirus Capsid Protein,” Vaccine, vol. 20, pp. 2454-2462, (2002).
Nash, P. et al., “Immunomodulation by Viruses: The Myxoma Virus Story,” Immunological Reviews, vol. 168, pp. 103-120, (1999).
Mayr, A. et al., “A New Concept in Prophylaxis and Therapy: Paramunization by Poxvirus Inducers,” Pesq. Vet. Bras., vol. 19, No. 3/4, pp. 91-98, (Jul. 1999).
Büttner, M., “Principles of Paramunization: Option and Limits in Veterinary Medicine,” Comp. Immun. Microbiol. Infect. Dis., vol. 16, No. 1, pp. 1-10, (1993).

Affiliated with

Also associated with

Rating

Paramunity inducers based on attenuated rabbit myxoma virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Paramunity inducers based on attenuated rabbit myxoma virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Paramunity inducers based on attenuated rabbit myxoma virus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4080651